Patents by Inventor Jeremy A. KROEMER

Jeremy A. KROEMER has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20220081695
    Abstract: Disclosed herein are methods of controlling insect pests which infest crop plants, in particular Spodoptera frugiperda (fall armyworm), Lygus hesperus (western tarnished plant bug), Euschistus heros (neotropical brown stink bug), and Plutella xylostella (diamondback moth), and methods of providing plants resistant to such pests. Also disclosed are polynucleotides and recombinant DNA molecules and constructs useful in such methods, insecticidal compositions such as topical sprays containing insecticidal double-stranded RNAs, and plants with improved resistance to infestation by these insects. Further disclosed are methods of selecting target genes for RNAi-mediated silencing and control of these insect pests.
    Type: Application
    Filed: August 13, 2021
    Publication date: March 17, 2022
    Applicant: Monsanto Technology LLC
    Inventors: James A. Baum, Brian D. Eads, Jeremy A. Kroemer, Christina Marie Taylor
  • Patent number: 11091770
    Abstract: Disclosed herein are methods of controlling insect pests which infest crop plants, in particular Spodoptera frugiperda (fall armyworm), Lygus hesperus (western tarnished plant bug), Euschistus heros (neotropical brown stink bug), and Plutella xylostella (diamondback moth), and methods of providing plants resistant to such pests. Also disclosed are polynucleotides and recombinant DNA molecules and constructs useful in such methods, insecticidal compositions such as topical sprays containing insecticidal double-stranded RNAs, and plants with improved resistance to infestation by these insects. Further disclosed are methods of selecting target genes for RNAi-mediated silencing and control of these insect pests.
    Type: Grant
    Filed: March 27, 2015
    Date of Patent: August 17, 2021
    Assignee: MONSANTO TECHNOLOGY LLC
    Inventors: James A. Baum, Brian D. Eads, Jeremy A. Kroemer, Christina Marie Taylor
  • Publication number: 20170183683
    Abstract: Disclosed herein are methods of controlling insect pests which infest crop plants, in particular Spodoptera frugiperda (fall armyworm), Lygus hesperus (western tarnished plant bug), Euschistus heros (neotropical brown stink bug), and Plutella xylostella (diamondback moth), and methods of providing plants resistant to such pests. Also disclosed are polynucleotides and recombinant DNA molecules and constructs useful in such methods, insecticidal compositions such as topical sprays containing insecticidal double-stranded RNAs, and plants with improved resistance to infestation by these insects. Further disclosed are methods of selecting target genes for RNAi-mediated silencing and control of these insect pests.
    Type: Application
    Filed: March 27, 2015
    Publication date: June 29, 2017
    Applicant: Monsanto Technology LLC
    Inventors: James A. BAUM, Brian D. EADS, Jeremy A. KROEMER, Christina Marie TAYLOR
  • Patent number: 7842493
    Abstract: It is the object of the current invention to provide methods and compositions relating to the expression of vankyrin proteins in cell lines to increase their viability, longevity and capacity for protein production. The inventors have discovered that the expression of P-ank-1 and I2-ank-3 proteins in cell culture has increased the cells' longevity and capacity for endogenous and/or heterologous target protein production. Specifically, the present invention relates to the enhanced expression of endogenous and/or heterologous target proteins/polypeptides in recombinant cells that are also expressing P-ank-1 and/or I2-ank-3 protein compared to expression host cells that are not expressing P-ank-1 and/or I2-ank-3 protein.
    Type: Grant
    Filed: September 24, 2009
    Date of Patent: November 30, 2010
    Assignee: University of Kentucky Research Foundation
    Inventors: Bruce Allen Webb, Jeremy Kroemer
  • Publication number: 20100099183
    Abstract: It is the object of the current invention to provide methods and compositions relating to the expression of vankyrin proteins in cell lines to increase their viability, longevity and capacity for protein production. The inventors have discovered that the expression of P-ank-1 and I2-ank-3 proteins in cell culture has increased the cells' longevity and capacity for endogenous and/or heterologous target protein production. Specifically, the present invention relates to the enhanced expression of endogenous and/or heterologous target proteins/polypeptides in recombinant cells that are also expressing P-ank-1 and/or I2-ank-3 protein compared to expression host cells that are not expressing P-ank-1 and/or I2-ank-3 protein.
    Type: Application
    Filed: September 24, 2009
    Publication date: April 22, 2010
    Inventors: BRUCE ALLEN WEBB, JEREMY KROEMER
  • Patent number: 7629160
    Abstract: It is the object of the current invention to provide methods and compositions relating to the expression of vankyrin proteins in cell lines to increase their viability, longevity and capacity for protein production. The inventors have discovered that the expression of P-ank-1 and I2-ank-3 proteins in cell culture has increased the cells' longevity and capacity for endogenous and/or heterologous target protein production. Specifically, the present invention relates to the enhanced expression of endogenous and/or heterologous target proteins/polypeptides in recombinant cells that are also expressing P-ank-1 and/or I2-ank-3 protein compared to expression host cells that are not expressing P-ank-1 and/or I2-ank-3 protein.
    Type: Grant
    Filed: December 21, 2004
    Date of Patent: December 8, 2009
    Assignee: University of Kentucky Research Foundation
    Inventors: Bruce Allen Webb, Jeremy Kroemer
  • Publication number: 20060134743
    Abstract: It is the object of the current invention to provide methods and compositions relating to the expression of vankyrin proteins in cell lines to increase their viability, longevity and capacity for protein production. The inventors have discovered that the expression of P-ank-1 and I2-ank-3 proteins in cell culture has increased the cells' longevity and capacity for endogenous and/or heterologous target protein production. Specifically, the present invention relates to the enhanced expression of endogenous and/or heterologous target proteins/polypeptides in recombinant cells that are also expressing P-ank-1 and/or I2-ank-3 protein compared to expression host cells that are not expressing P-ank-1 and/or I2-ank-3 protein.
    Type: Application
    Filed: December 21, 2004
    Publication date: June 22, 2006
    Inventors: Bruce Webb, Jeremy Kroemer